A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Cancer
Related studies linked through entity extraction aliases.
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Variation in Cancer Centers' End-of-Life Quality
- Status
- COMPLETED
- Phase
- N/A
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents
- Status
- COMPLETED
- Phase
- NA
Psychosocial Intervention in Latino Patients with Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
MGD019 DART® Protein in Unresectable/Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
POEM (Practice of Embracing Each Moment) Study (Delivery Science)
- Status
- COMPLETED
- Phase
- NA
An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies
- Status
- SUSPENDED
- Phase
- PHASE1
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
DM-CHOC-PEN for Brain Tumors in AYA Subjects
- Status
- COMPLETED
- Phase
- PHASE2
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Carrying TP53 Harmful Mutations
- Status
- UNKNOWN
- Phase
- PHASE1